1. Bayer AS, Seidel JS, Yoshikawa TT, Anthony BF, Guze LB. Group D
Enterococcal meningitis. Clinical and therapeutic considerations with report of three cases and review of the literature. Arch Intern Med. 1976. 136:883–886.
Article
2. Shin JW, Yong D, Kim MS, Chang KH, Lee K, Kim JM, Chong Y. Sudden increase of vancomycin-resistant enterococcal infections in a Korean tertiary care hospital: possible consequences of increased use of oral vancomycin. J Infect Chemother. 2003. 9:62–67.
Article
3. Evans GA. The Oxazolidinones. Curr Infect Dis Rep. 2002. 4:17–27.
Article
4. Huycke MM, Sahm DF, Gilmore MS. Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerg Infect Dis. 1998. 4:239–249.
Article
5. Shaikh ZH, Peloquin CA, Ericsson CD. Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with linezolid: case report and literature review. Scand J Infect Dis. 2001. 33:375–379.
6. Zeana C, Kubin CJ, Della-Latta P, Hammer SM. Vancomycin-resistant
Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature. Clin Infect Dis. 2001. 33:477–482.
Article
7. Hachem R, Afif C, Gokaslan Z, Raad I. Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid. Eur J Clin Microbiol Infect Dis. 2001. 20:432–434.
Article
8. Steinmetz MP, Vogelbaum MA, De Georgia MA, Andrefsky JC, Isada C. Successful treatment of vancomycin-resistant enterococcus meningitis with linezolid: case report and review of the literature. Crit Care Med. 2001. 29:2383–2385.
Article
9. Tsai TN, Wu CP, Peng MY, Giian CF, Lee SY, Lu JJ. Short course of linezolid treatment for vancomycin-resistant
Enterococcus faecium meningitis. Int J Clin Pract. 2006. 60:740–741.
Article
10. Kumar S, Kohlhoff S, Valencia G, Hammerschlag MR, Sharma R. Treatment of vancomycin-resistant
Enterococcus faecium ventriculitis in a neonate. Int J Antimicrob Agents. 2007. 29:740–741.
Article
11. Mizell KN, Carter JE. Vancomycin-resistant
Enterococcus faecium meningitis successfully treated with linezolid. South Med J. 2008. 101:569–570.
Article
12. Ryu WS, Bae EK, Kim JS, Erm GH, Jung KH, Park HK, Chu K. Vancomycin-resistant Enterococcus meningitis. J Korean Neurol Assoc. 2008. 26:273–276.
13. Losonsky GA, Wolf A, Schwalbe RS, Nataro J, Gibson CB, Lewis EW. Successful treatment of meningitis due to multiply resistant
Enterococcus faecium with a combination of intrathecal teicoplanin and intravenous antimicrobial agents. Clin Infect Dis. 1994. 19:163–165.
Article
14. Nachman SA, Verma R, Egnor M. Vancomycin-resistant
Enterococcus faecium shunt infection in an infant: an anti-biotic cure. Microb Drug Resist. 1995. 1:95–96.
Article
15. Tush GM, Huneycutt S, Phillips A, Ward JD. Intraventricular quinupristin/dalfopristin for the treatment of vancomycin-resistant
Enterococcus faecium shunt infection. Clin Infect Dis. 1998. 26:1460–1461.
Article
16. Williamson JC, Glazier SS, Peacock JE Jr. Successful treatment of ventriculostomy-related meningitis caused by vancomycin-resistant Enterococcus with intravenous and intraventricular quinupristin/dalfopristin. Clin Neurol Neurosurg. 2002. 104:54–56.
Article
17. Tan TY, Pitman I, Penrose-Stevens A, Simpson BA, Flanagan PG. Treatment of a vancomycin-resistant Enterococcus faecium ventricular drain infection with quinupristin/dalfopristin and review of the literature. J Infect. 2000. 41:95–97.
18. Tarasi A, Dever LL, Tomasz A. Activity of quinupristin/dalfopristin against
Streptococcus pneumoniae in vitro and in vivo in the rabbit model of experimental meningitis. J Antimicrob Chemother. 1997. 39:Suppl A. 121–127.
Article